🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of the Effectiveness of Mulligan Mobilization and Myofascial Release Technique in Patients With Lateral Epicondylitis

RecruitingNAAges 18 Years - 65 YearsAllKonya Beyhekim Training and Research Hospital
NCT06965985 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Lateral epicondylitis (LE), recognized as one of the most prevalent causes of elbow pain, has an estimated incidence ranging from 1% to 3%. It most commonly presents in individuals between the ages of 40 and 50 and tends to affect the dominant limb more frequently. In the adult population, LE is the leading cause of lateral elbow pain. To date, more than 40 different treatment modalities have been described for the management of LE, primarily aiming to alleviate pain and enhance functional outcomes. However, a universally accepted standard treatment has yet to be established. The objective of this thesis is to compare the clinical effectiveness of the Mulligan mobilization technique and the myofascial release technique-both commonly utilized in the treatment of LE-through a prospective clinical study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Aged between 18 and 65 years Diagnosed with unilateral lateral epicondylitis (LE) Exclusion Criteria: Younger than 18 or older than 65 years Communication difficulties History of injection, surgery, or physical therapy in the elbow region within the past 6 months Pain originating from the cervical spine (e.g., radiculopathy, spinal stenosis), shoulder problems, or other elbow pathologies unrelated to LE History of elbow osteoarthritis or previous elbow fracture History of polyneuropathy Uncontrolled systemic diseases (e.g., cardiovascular, pulmonary, hepatic, renal, hematologic disorders) Uncontrolled systemic endocrine disorders (e.g., diabetes mellitus, hyperthyroidism) History of major psychiatric disorders History of rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, or rheumatoid arthritis Presence of bleeding disorders or use of anticoagulant medications Neurological deficits Posterior interosseous nerve (PIN) syndrome Current or past use of wrist resting splints or elbow braces
💊

What it tests

  • Mulligan mobilization therapy
  • Myofascial release therapy
  • Exercise Therapy
📍

Where

1 site
Konya Beyhekim Eğitim ve Araştırma Hastanesi
Konya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy